Los Angeles Capital Management
INSP icon

Los Angeles Capital Management’s Inspire Medical Systems INSP Stock Holding History

Los Angeles Capital Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.29K Sell
141
-132,813
-100% -$6.3M ﹤0.01% 2079
2026
Q1 		$6.86M Buy
132,954
+132,813
+94,194% +$9.3M 0.03% 292
2025
Q4 		$10.3K Buy
+141
New +$13.5K ﹤0.01% 2068
2025
Q3 		– Sell
-136,950
Closed -$17.8M – 1442
2025
Q2 		$17.8M Buy
136,950
+776
+0.6% +$113K 0.07% 182
2025
Q1 		$21.7M Buy
136,174
+45,632
+50% +$8.26M 0.1% 157
2024
Q4 		$16.8M Buy
90,542
+47,563
+111% +$9.23M 0.07% 197
2024
Q3 		$9.07M Buy
+42,979
New +$7.47M 0.04% 260
2024
Q1 		– Sell
-1,583
Closed -$322K – 1174
2023
Q4 		$322K Sell
1,583
-53,609
-97% -$8.69M ﹤0.01% 998
2023
Q3 		$11M Sell
55,192
-32,990
-37% -$8.32M 0.05% 237
2023
Q2 		$28.6M Buy
88,182
+79,766
+948% +$22.8M 0.11% 158
2023
Q1 		$1.97M Buy
8,416
+1,862
+28% +$471K 0.01% 504
2022
Q4 		$1.65M Sell
6,554
-347
-5% -$74K 0.01% 567
2022
Q3 		$1.22M Buy
6,901
+422
+7% +$84.8K 0.01% 630
2022
Q2 		$1.18M Hold
6,479
– – 0.01% 662
2022
Q1 		$1.66M Buy
6,479
+54
+0.8% +$12.3K 0.01% 588
2021
Q4 		$1.48M Sell
6,425
-77
-1% -$18.8K 0.01% 596
2021
Q3 		$1.51M Hold
6,502
– – 0.01% 600
2021
Q2 		$1.26M Sell
6,502
-690
-10% -$137K 0.01% 759
2021
Q1 		$1.49M Sell
7,192
-4,729
-40% -$1M 0.01% 730
2020
Q4 		$2.24M Buy
11,921
+6,901
+137% +$1.13M 0.01% 619
2020
Q3 		$648K Buy
5,020
+80
+2% +$8.81K ﹤0.01% 987
2020
Q2 		$430K Buy
+4,940
New +$380K ﹤0.01% 1169
2020
Q1 		– Sell
-3,450
Closed -$256K – 1408
2019
Q4 		$256K Sell
3,450
-1,120
-25% -$72K ﹤0.01% 1160
2019
Q3 		$279K Hold
4,570
– – ﹤0.01% 1137
2019
Q2 		$277K Hold
4,570
– – ﹤0.01% 1209
2019
Q1 		$259K Buy
+4,570
New +$247K ﹤0.01% 1240

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Los Angeles Capital Management's INSP Position: Q2 2026 in Review

Los Angeles Capital Management reduced its Inspire Medical Systems (INSP) stake by 100% in Q2 2026, selling an estimated $6.3M and leaving 141 shares worth $6.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2079.

Los Angeles Capital Management first reported a position in INSP in Q1 2019 and has held it in 26 quarters since. The position peaked at $28.6M in Q2 2023. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Los Angeles Capital Management held 141 shares of Inspire Medical Systems worth $6.29K as of Q2 2026.
  • Los Angeles Capital Management sold 132,813 Inspire Medical Systems shares in Q2 2026, an estimated $6.3M.
  • Inspire Medical Systems made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #2079 holding.
  • Los Angeles Capital Management first reported a position in Inspire Medical Systems in Q1 2019 and has held it in 26 quarters since.
  • Los Angeles Capital Management's Inspire Medical Systems position peaked at $28.6M in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.